日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Marker-assisted enhancement of bacterial blight (Xanthomonas oryzae pv. oryzae) resistance in a salt-tolerant rice variety for sustaining rice production of tropical islands

利用分子标记辅助增强耐盐水稻品种对细菌性枯萎病(水稻黄单胞菌致病变种)的抗性,以维持热带岛屿水稻生产

Gautam, Raj Kumar; Singh, Pankaj Kumar; Sakthivel, Krishnan; Venkatesan, K; Rao, Shyam S; Srikumar, M; Vijayan, Joshitha; Rakesh, B; Ray, Soham; Akhtar, Jameel; Meena, Bharat Raj; Langyan, Sapna; Ali, Sharik; Krishnamurthy, S L

CHIP/STUB1 Ubiquitin Ligase Functions as a Negative Regulator of ErbB2 by Promoting Its Early Post-Biosynthesis Degradation

CHIP/STUB1 泛素连接酶通过促进 ErbB2 生物合成后早期降解,发挥其负调节作用

Haitao Luan, Tameka A Bailey, Robert J Clubb, Bhopal C Mohapatra, Aaqib M Bhat, Sukanya Chakraborty, Namista Islam, Insha Mushtaq, Matthew D Storck, Srikumar M Raja, Vimla Band, Hamid Band

Marked enhancement of lysosomal targeting and efficacy of ErbB2-targeted drug delivery by HSP90 inhibition

通过抑制 HSP90 显著增强溶酶体靶向性和 ErbB2 靶向药物输送的功效

Srikumar M Raja, Swapnil S Desale, Bhopal Mohapatra, Haitao Luan, Kruti Soni, Jinjin Zhang, Matthew A Storck, Dan Feng, Timothy A Bielecki, Vimla Band, Samuel M Cohen, Tatiana K Bronich, Hamid Band

Polypeptide-based nanogels co-encapsulating a synergistic combination of doxorubicin with 17-AAG show potent anti-tumor activity in ErbB2-driven breast cancer models

多肽基纳米凝胶与阿霉素和 17-AAG 协同组合,在 ErbB2 驱动的乳腺癌模型中表现出强大的抗肿瘤活性

Swapnil S Desale, Srikumar M Raja, Jong Oh Kim, Bhopal Mohapatra, Kruti S Soni, Haitao Luan, Stetson H Williams, Timothy A Bielecki, Dan Feng, Matthew Storck, Vimla Band, Samuel M Cohen, Hamid Band, Tatiana K Bronich

A kinase inhibitor screen reveals protein kinase C-dependent endocytic recycling of ErbB2 in breast cancer cells

激酶抑制剂筛选揭示了乳腺癌细胞中ErbB2的蛋白激酶C依赖性内吞循环

Tameka A Bailey ,Haitao Luan ,Eric Tom ,Timothy Alan Bielecki ,Bhopal Mohapatra ,Gulzar Ahmad ,Manju George ,David L Kelly ,Amarnath Natarajan ,Srikumar M Raja ,Vimla Band ,Hamid Band

Protein tyrosine kinase regulation by ubiquitination: critical roles of Cbl-family ubiquitin ligases

泛素化对蛋白酪氨酸激酶的调控:Cbl家族泛素连接酶的关键作用

Mohapatra, Bhopal; Ahmad, Gulzar; Nadeau, Scott; Zutshi, Neha; An, Wei; Scheffe, Sarah; Dong, Lin; Feng, Dan; Goetz, Benjamin; Arya, Priyanka; Bailey, Tameka A; Palermo, Nicholas; Borgstahl, Gloria E O; Natarajan, Amarnath; Raja, Srikumar M; Naramura, Mayumi; Band, Vimla; Band, Hamid

Anticancer activity of Celastrol in combination with ErbB2-targeted therapeutics for treatment of ErbB2-overexpressing breast cancers

雷公藤内酯醇与靶向ErbB2的疗法联合治疗ErbB2过表达乳腺癌的抗癌活性

Raja, Srikumar M; Clubb, Robert J; Ortega-Cava, Cesar; Williams, Stetson H; Bailey, Tameka A; Duan, Lei; Zhao, Xiangshan; Reddi, Alagarasamy L; Nyong, Abijah M; Natarajan, Amarnath; Band, Vimla; Band, Hamid

Negative regulation of EGFR-Vav2 signaling axis by Cbl ubiquitin ligase controls EGF receptor-mediated epithelial cell adherens junction dynamics and cell migration

Cbl 泛素连接酶对 EGFR-Vav2 信号轴的负向调控控制 EGF 受体介导的上皮细胞黏附连接动力学和细胞迁移

Lei Duan, Srikumar M Raja, Gengsheng Chen, Sumeet Virmani, Stetson H Williams, Robert J Clubb, Chandrani Mukhopadhyay, Mark A Rainey, Guoguang Ying, Manjari Dimri, Jing Chen, Alagarsamy L Reddi, Mayumi Naramura, Vimla Band, Hamid Band

Continuous requirement of ErbB2 kinase activity for loss of cell polarity and lumen formation in a novel ErbB2/Neu-driven murine cell line model of metastatic breast cancer

在新型 ErbB2/Neu 驱动的转移性乳腺癌小鼠细胞系模型中,ErbB2 激酶活性的持续存在对于细胞极性丧失和管腔形成至关重要。

Ortega-Cava, Cesar F; Raja, Srikumar M; Laiq, Zenab; Bailey, Tameka A; Luan, Haitao; Mohapatra, Bhopal; Williams, Stetson H; Ericsson, Aaron C; Goswami, Rasna; Dimri, Manjari; Duan, Lei; Band, Vimla; Naramura, Mayumi; Band, Hamid

Mechanisms of Trastuzumab resistance in ErbB2-driven breast cancer and newer opportunities to overcome therapy resistance

ErbB2驱动型乳腺癌中曲妥珠单抗耐药的机制及克服耐药性的新契机

Bailey, Tameka A; Luan, Haitao; Clubb, Robert J; Naramura, Mayumi; Band, Vimla; Raja, Srikumar M; Band, Hamid